TNNT2 and cancer: Further longitudinal studies are undoubtedly warranted to confirm our preliminary findings, to ascertain the prognostic value of elevated hs-cTnT levels, and to validate the use of hs-cTnT as a biomarker for screening of anthracycline cardiotoxicity in long-term survivors of childhood cancers.